Driving Collaboration Across Functions to Streamline Drug Development
Integrated teams, data visualization, and full-service coordination between clinical, regulatory, and commercial functions can accelerate decision-making and development speed.
Ben Edwards, chief operating officer at Avance Clinical, discussed common challenges in biotech in a recent video interview with Applied Clinical Trials. He emphasized the importance of addressing preclinical package gaps to avoid delays and highlighted the need for CROs with deep scientific capabilities.
Obtaining patient data early to inform decision-making is crucial in the current funding climate.
Edwards also noted the shift towards adaptive trial designs and the benefits of staying with the same CRO for continuity. Effective coordination across functions requires integrated teams and data visualization.
Author's summary: Collaboration accelerates drug development speed.
- Integrated teams and data visualization accelerate decision-making
- CROs with deep scientific capabilities create a sound scientific argument for new drugs
- Adaptive trial designs and continuity with the same CRO are beneficial